Question for written answer E-007032/2011 to the Commission Rule 117 Marian Harkin (ALDE) (18 July 2011) Subject: Review of herbal species Why has the Committee on Herbal Medicinal Products (HMPC) of the European Medicines Agency (EMA) reviewed so few herbal species associated with Chinese, Tibetan, Ayurvedic, Amazonian, African or other very long-established, non-European, healthcare traditions?